Covaxin gets emergency use approval in kids between 2-18 age group

0
220
DCGI Gives Nod To Market Authorization Of Two Covid Vaccines
DCGI Gives Nod To Market Authorization Of Two Covid Vaccines

October 12

Bharat Biotech’s Covaxin has got the emergency use approval for children in the age group of 2 to 18 years from the Drugs Controller General of India (DCGA).

Bharat Biotech had earlier submitted the Phase II & III trail data of Covaxin on Children to DCGI.

The Subject Expert Committee on Covid-19 gave the approval for the emergency use in the children.

The vaccine will be administered in two doses with 20 days of interval.

The expert panel said in a statement, “After detailed deliberation, the committee recommended for grant of market authorisation of the vaccine for the age group of 2 to 18 years for restricted use in emergency situation.”

Bharat Biotech needs to submit safety data with due analysis every 15 days for the first two months and monthly thereafter.

Also Read  Dr Henk Bekedam new WHO representative to India

LEAVE A REPLY

Please enter your comment!
Please enter your name here